ascendis pharma glp-1 receptor agonist Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug GLP1 Receptor Agonists—Effects beyond Obesity
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15





























